Patent · US Active

ALK5 inhibitors

US11730720B2 · kind B2 · utility

0Cited by
1References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2020
Grant dateAug 22, 2023
Priority date—
Expiry dateAug 29, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.